Login  |  Registrieren

Live Stats

Pharmaceuticals | Bayer - Home

Bayer initiates Phase III trial of Aflibercept to prevent blindness in premature infants. 2019-06-19. Regorafenib to be tested in brain cancer patients in multi-arm cooperation trial. 2019-06-04. Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants.

Alexa Traffic


Listing Links